Kinnate Biopharma Inc is a clinical-stage precision oncology company focused on the discovery, design, and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Nima Farzan$125.1M
Market Cap • 03/04/20242018
(há 6 anos)
2020
(4 years ago)
NASDAQ
Listagem
San Francisco
Sede • California84
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
KNTESó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.